Encouraging Biomarker Data Lift UniQure’s Huntington’s Disease Hopes

Results Exceeded Expectations

 
• By Andrew McConaghie
  
UniQure
The safety and biomarker data are encouraging, but it will take until 2023 before any potential disease modifying data are available. • Source: UniQure
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip